Amerikaanse aandelen « Terug naar discussie overzicht

HOT stocks vandaag.

12.177 Posts, Pagina: « 1 2 3 4 5 6 ... 597 598 599 600 601 602 603 604 605 606 607 608 609 » | Laatste

Omlaag ↓

[verwijderd] 24 februari 2015 15:55

Kijk nog 's.

[verwijderd] 24 februari 2015 19:22

Ja, zag het. Toch nog met terugwerkende kracht mezelf een schouderklopje gegeven...

[verwijderd] 24 februari 2015 19:29

In DIDG .001

[verwijderd] 24 februari 2015 20:15

Uit DIDG .0011
10% gain

[verwijderd] 24 februari 2015 21:15

sta weer op de bid DIDG .001

[verwijderd] 25 februari 2015 17:21

Weer in DIDG .0009/.001

[verwijderd] 26 februari 2015 18:09

Uit DIDG break even.
Ik zie het niet meer gebeuren!

In ECIG .132

[verwijderd] 27 februari 2015 18:04

ECIG .143

[verwijderd] 27 februari 2015 18:05

Uit ECIG 0.144
9.1% gain

[verwijderd] 27 februari 2015 18:52

EVDR news!!!
www.prnewswire.com/news-releases/crit...

.0008
Nu nog goedkoop, maar ze hebben grote plannen daar.

[verwijderd] 2 maart 2015 15:53

Ik ga vandaag all cash, op m,n EVDR aandeeltjes na, want freeshares!
Ik vertrek morgen naar curacao voor 11 dagen, dus even op non actief!

Tot dan!

Tip:

Hou de komende tijd MBLX , EVDR , MEA , LEDS in de gaten!

[verwijderd] 2 maart 2015 23:49

Have fun Gerrit.

[verwijderd] 3 maart 2015 00:02

Curacao ? dat is pas HOT stock:)

[verwijderd] 4 maart 2015 17:03

KBIO

[verwijderd] 14 maart 2015 13:06

Zo ik ben weer terug!
even lekker batterij opgeladen in het zonnetje.

Deze week maar weer eens rustig beginnen.

[verwijderd] 14 maart 2015 20:29

Kijk, Gerrit ook weer op stok. Of beter gezegd: op stock.

[verwijderd] 15 maart 2015 19:33

Haha mooi man!

Vanavond een beetje aan het scannen geweest, en wel wat stocks gezien die aandacht verdienen.

[verwijderd] 15 maart 2015 20:43

Mooi, heb nog wat dood geld overgemaakt en kan eventueel aan de knoppen zitten morgen. Let the games begin.

StephanO 15 maart 2015 21:14

LLBO is ook uit de startblokken geschoten. Nog steeds is er enorm rendement te behalen. 2015 wordt een belangrijk jaar voor LLBO. Vond het volgende artikel op CNN money. Aandeel noteert nu 0,004

The Company (OTC PINK: LLBO) (PINKSHEETS: LLBO) updates the meaningful activities for First Quarter of 2015:
In 2008 Lifeline Biotechnologies exclusively licensed its First Warning Systems technology to First Warning Systems, Inc., (now called Cyrcadia Health) via a revenue royalty license of its patented, circadian rhythm based, pattern recognition technology. Three rounds of proof of concept trials were conducted and validated by the foremost pattern recognition engineers in the world (the Engineers at Nanyang Technological University in Singapore).
LLBO's primary asset is its investment in Cyrcadia Inc. (Cyrcadia). That investment is achieving meaningful added value as Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH. The trials have been approved through Investigational Review Boards (IRB's) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.
It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU. Dr. Farrar published on the results of this study, commenting on the potential of this lifesaving technology that could assist in the early detection of breast tissue abnormalities and breast cancers. A copy of Dr. Farrar's abstract will be posted on the Lifeline website in the next few days.
Other developments:
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

money.cnn.com/news/newsfeeds/articles...

Verder vond ik vandaag het volgende:

LIFELINE BIOTECH (OTCMKTS:LLBO) is making a spectacular move up on massive volume in recent days. Over the past few months LLBO has transformed from illiquid at $0.0001 to one of the top traded stocks on the entire bb.

LLBO move up is marked by steady accumulation and excellent support as the stock explode in sub penny land recently topping 100 million shares traded in daily trading volume.

LIFELINE BIOTECH (OTCMKTS:LLBO) was founded in 1994 and is based in Reno, NV. The Company has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer. Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded.

LLBO owns 40% of Cyrcadia Health who’s product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO).

Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets.

On March 12 LLBO updates the meaningful activities for First Quarter of 2015: In 2008 Lifeline Biotechnologies exclusively licensed its First Warning Systems technology to First Warning Systems, Inc., (now called Cyrcadia Health) via a revenue royalty license of its patented, circadian rhythm based, pattern recognition technology. Three rounds of proof of concept trials were conducted and validated by the foremost pattern recognition engineers in the world (the Engineers at Nanyang Technological University in Singapore).

LLBO’s primary asset is its investment in Cyrcadia Inc. That investment is achieving meaningful added value as Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH.

The trials have been approved through Investigational Review Boards (IRB’s) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months.

On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.

It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original “proof of concept” study that was conducted at OSU. Dr. Farrar published on the results of this study, commenting on the potential of this lifesaving technology that could assist in the early detection of breast tissue abnormalities and breast cancers. A copy of Dr. Farrar’s abstract will be posted on the Lifeline website in the next few days.

www.microcapdaily.com/stock-on-the-mo...

Fijne avond

[verwijderd] 16 maart 2015 14:39

Mooi volume LLBO.
Alleen heeft ie nogal wat nodig omte bewegen, wat is de ss, ik kan het zo gauw niet vinden.

12.177 Posts, Pagina: « 1 2 3 4 5 6 ... 597 598 599 600 601 602 603 604 605 606 607 608 609 » | Laatste

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

AEX 924,10 -1,03 -0,11% 07 feb


Germany40^	21.738,40	-0,75%
BEL 20	4.337,66	+0,00%
Europe50^	5.319,41	-0,11%
US30^	44.342,20	0,00%
Nasd100^	21.508,40	0,00%
US500^	6.029,92	0,00%
Japan225^	38.404,40	0,00%
Gold spot	2.860,78	0,00%
EUR/USD	1,0327	0,00%
WTI	70,95	0,00%